RxDoctor Payments Data

Carey Cano

Medical · Vallejo, CANPI 1114986809

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $13,331 of the $16,430 with a category attached, or 81.1%. It is spread thinly across 24 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $5,735, 3.3 times the $1,733 reported in 2021. Among medical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,430in general payments, 2019–2025

Across 503 payments — averaging $32.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$3K
  • AbbVie$2K
  • Arcutis Biotherapeutics, Inc.$2K
  • Regeneron Healthcare Solutions, Inc.$2K
  • Sanofi$1K
  • Incyte Corporation$1K
  • plus $5K from 18 others

What the payments were for

  • Consulting fees$2,29414%
  • Food & beverage$13,33181%
  • Education$8065%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,430 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.

See all medical providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Unoready PenSecukinumab18$353,463
Dupixent PenDupilumab69$257,528
OpzeluraRuxolitinib Phosphate38$77,485
Dupixent SyringeDupilumab15$66,542
ZoryveRoflumilast17$15,420
Clobetasol Propionate83$4,945
Fluorouracil15$1,223
Ciclopirox23$964
Betamethasone Dipropionate15$645
Tacrolimus11$596
Fluocinonide15$492
Desonide17$440
Hydroxychloroquine Sulfate14$421
Ketoconazole29$361
Minoxidil13$134

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Incyte CorporationOpzelura$1,281$77,48538 claims
Arcutis Biotherapeutics, Inc.Zoryve$1,776$15,42017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 medical providers in California.

Other medical in Vallejo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →